Ingredients of Vicks VapoRub inhibit rhinovirus-induced ATP release

Rebecca J Stinson, Alyn H Morice, Basir Ahmad, Laura R Sadofsky

Article Type

Original Research

Published

This article suggests that some Vicks VapoRub ingredients may reduce symptoms associated with upper respiratory tract infection by modulating specific TRP receptors and by reducing RV16-induced ATP release.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.